Picture of Sensus Healthcare logo

SRTS Sensus Healthcare News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Sensus Healthcare Announces Study Showing Single Low Dose Of Superficial Radiation Therapy Prevents Keloid Recurrence Following Surgical Excision

Dec 1 (Reuters) - Sensus Healthcare Inc  SRTS.O :
    * SENSUS HEALTHCARE ANNOUNCES STUDY SHOWING SINGLE LOW DOSE
OF
SUPERFICIAL RADIATION THERAPY PREVENTS KELOID RECURRENCE
FOLLOWING SURGICAL EXCISION
    * SENSUS HEALTHCARE INC - SINGLE LOW DOSE OF SRT FOLLOWING
EXCISION OF 14 KELOIDS HAD AN APPROXIMATE 6.25% RECURRENCE RATE
AT SIX MONTHS
    * SENSUS HEALTHCARE INC - FOR 10 PATIENTS AVAILABLE FOR
FOLLOW-UP
AT 24 MONTHS NONE OF KELOIDS HAD RECURRED

Source text for Eikon:  ID:nGNX9l8QwL 
Further company coverage:  SRTS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sensus Healthcare

See all news